We found 157 records for "Financial"

Articles

Repairing the disconnect in medical technology

19th June 2014

 Repairing the disconnect in medical technology Articles

Powerful external forces are disrupting the traditional strategies of medical technology leaders as companies face greater economic pressures, a reformed health care system, new hospital and physician alignments, and new...

Read more

The trend to blend: M&A in pharma - Are you ready?

17th June 2014

 The trend to blend: M&A in pharma - Are you ready?Articles

Paul Gershlick and Laura Barrell examine the recent surge in mergers and acquisitions, and look at what small to medium sized firms can do to make themselves more attractive to...

Read more

US patient assistance programmes - a critique

6th June 2014

 US patient assistance programmes - a critiqueArticles

Financial support given to patients is receiving more demand in the US, totalling an estimated $15 billion, but are patient assistance programmes good for either patients or pharmaceutical companies, and...

Read more

Pharma gets social: Pfizer and AstraZeneca in pharma’s biggest ever social media explosion?

15th May 2014

 Pharma gets social: Pfizer and AstraZeneca in pharma’s biggest ever social media explosion?Articles

Daniel Ghinn explores the buzz of social media around the Pfizer / AstraZeneca news story. The huge volume of social media activity around the story, as it has been breaking,...

Read more

News

Australian Health Minister's bid to censor CF comments backfires

28th July 2014

 Australian Health Minister's bid to censor CF comments backfiresNews

Australia's Health Minister Peter Dutton may be regretting his decision to remove posts on his Facebook account complaining about access to Vertex' cystic fibrosis drug Kalydeco.Patients and carers for people...

Read more

Synthetic biology firm raises $29m

28th July 2014

 Synthetic biology firm raises $29mNews

A US company set up to create engineered bacteria that can both detect and treat diseases has raised $29 million in funding from venture capitalists.Atlas Ventures and New Enterprise Associates...

Read more

GSK struggles to maintain respiratory dominance

24th July 2014

 GSK struggles to maintain respiratory dominanceNews

Something seems to be going awry with GlaxoSmithKline's game plan for its respiratory franchise, with new products positioned to replace ageing blockbuster Advair/Seretide not performing in the field.Group sales fell...

Read more

Shire growth shows AbbVie's interest goes beyond tax

23rd July 2014

 Shire growth shows AbbVie's interest goes beyond taxNews

The headline news in AbbVie's pursuit of Shire may be the opportunity to reduce its tax, but Shire's second-quarter financial results suggest there is plenty more in the deal to...

Read more

White Papers

Redefining Market Access - Effective Value Engagement

3rd December 2013

 Redefining Market Access - Effective Value EngagementWhite Papers

Phenestra's latest white paper highlights the challenges in market access and reimbursement for every company involved in developing new and innovative drugs.Today, every pharmaceutical company has the patient at the...

Read more

Audio & Video

Webinar: 9 July - The future of UK pharma

The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health forecasts the global market will see a compound average growth...

Read more

Events

3rd Pharma Packaging and Labelling Forum

11th September 2014 - 12th September 2014

3rd Pharma Packaging and Labelling Forum

With current regulatory strictness and non-easing economical atmosphere pharma companies have an intensifying need to focus on complying with restrictions while keeping their efficiency & cost-cutting initiatives. With new...

Read more

Big Data in Pharma

16th September 2014 - 19th September 2014

Big Data in Pharma

To cut through the Big Data hype, and yield actionable, measurable insights to transform the pharma and healthcare sector requires leveraging the experiences of the leading pharma executives and top...

Read more

Big Data in Pharma

23rd September 2014

Big Data in Pharma

The volume of data is exploding, challenging drug makers’ ability to transform this data into additional revenue. But companies who can exploit big data and analytics have the potential to...

Read more

Orphan Drugs, Collaborations and Market Access Congress

29th September 2014 - 30th September 2014

Orphan Drugs, Collaborations and Market Access Congress

Stream 1 - Market Access - Partnerships, VC Investment & Strategy Stream 2 - Orphan Drugs Case Studies Stream 3 - Emerging Therapies & Technology Uses/Genome Mapping & Screening Technologies Stream 4 -...

Read more

Press Releases

Aqurance launches Market Research & Predictive Analytics Services

3rd July 2014

Aqurance launches Market Research & Predictive Analytics Services

Athens, GR, July 02, 2014: Aqurance, a dynamic startup that specializes inLife Sciences consulting and technology implementation services, has recently announced the launch of a new business department, the Market...

Read more